Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Subscriptions payable
Accumulated deficit
Total
Balances at Dec. 31, 2020 $ 85 $ 9,896 $ 25,920,858 $ (20,196,823) $ 5,734,016
Balances (in Shares) at Dec. 31, 2020 84,872 9,895,600        
Conversion of Series A Convertible Preferred Stock into common stock $ (20) $ 72 (52)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (20,000) 72,369        
Shares issued for vested restricted stock units $ 9 (9)
Shares issued for vested restricted stock units (in Shares) 8,832        
Shares issued for equity financing $ 53 249,947 250,000
Shares issued for equity financing (in Shares) 52,632        
Stock based compensation 500,718 500,718
Net Loss (747,943) (747,943)
Balances at Mar. 31, 2021 $ 65 $ 10,030 26,671,462 (20,944,766) 5,736,791
Balances (in Shares) at Mar. 31, 2021 64,872 10,029,433        
Balances at Dec. 31, 2021 $ 40 $ 11,293 29,805,028 600,000 (24,011,291) 6,405,070
Balances (in Shares) at Dec. 31, 2021 39,810 11,293,030        
Shares issued as settlement of accounts payable $ 84 84,916 85,000
Shares issued as settlement of accounts payable (in Shares) 83,954        
Shares issued for vested restricted stock units $ 19 (19)
Shares issued for vested restricted stock units (in Shares) 18,666        
Stock based compensation 347,568 347,568
Net Loss (626,546) (626,546)
Balances at Mar. 31, 2022 $ 40 $ 11,396 $ 30,237,493 $ 600,000 $ (24,637,837) $ 6,211,092
Balances (in Shares) at Mar. 31, 2022 39,810 11,395,650